Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 281.72B | 281.72B | 245.12B | 211.91B | 198.27B | 168.09B |
Gross Profit | 193.89B | 193.89B | 171.01B | 146.05B | 135.62B | 115.86B |
EBITDA | 160.16B | 160.16B | 133.01B | 105.14B | 100.24B | 85.13B |
Net Income | 101.83B | 101.83B | 88.14B | 72.36B | 72.74B | 61.27B |
Balance Sheet | ||||||
Total Assets | 619.00B | 619.00B | 512.16B | 411.98B | 364.84B | 333.78B |
Cash, Cash Equivalents and Short-Term Investments | 94.56B | 94.56B | 75.53B | 111.26B | 104.75B | 130.26B |
Total Debt | 60.59B | 112.18B | 67.13B | 59.97B | 61.27B | 67.78B |
Total Liabilities | 275.52B | 275.52B | 243.69B | 205.75B | 198.30B | 191.79B |
Stockholders Equity | 343.48B | 343.48B | 268.48B | 206.22B | 166.54B | 141.99B |
Cash Flow | ||||||
Free Cash Flow | 71.61B | 71.61B | 74.07B | 59.48B | 65.15B | 56.12B |
Operating Cash Flow | 136.16B | 136.16B | 118.55B | 87.58B | 89.03B | 76.74B |
Investing Cash Flow | -72.60B | -72.60B | -96.97B | -22.68B | -30.31B | -27.58B |
Financing Cash Flow | -51.70B | -51.70B | -37.76B | -43.94B | -58.88B | -48.49B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
85 Outperform | $3.88T | 38.25 | 33.28% | 0.62% | 14.93% | 15.50% | |
77 Outperform | $144.67B | 21.81 | 52.25% | ― | 10.69% | 40.10% | |
77 Outperform | $105.80B | 721.64 | -5.76% | ― | 25.94% | -226.80% | |
76 Outperform | $111.51B | 95.60 | 21.16% | ― | 13.91% | -50.96% | |
75 Outperform | $702.35B | 57.59 | 85.36% | 0.71% | 8.38% | 16.96% | |
71 Outperform | $57.14B | 29.76 | 165.17% | ― | 14.46% | 48.06% | |
61 Neutral | $35.87B | 6.13 | -9.30% | 2.06% | 7.63% | -6.38% |
Microsoft Corporation’s Board of Directors has amended the company’s Bylaws, effective July 1, 2025, to introduce a cure process for deficiencies in director nomination notices submitted by shareholders. This change allows shareholders to rectify any issues in their nomination notices within a specified time, potentially impacting shareholder engagement and governance practices.
The most recent analyst rating on (MSFT) stock is a Buy with a $511.00 price target. To see the full list of analyst forecasts on Microsoft stock, see the MSFT Stock Forecast page.